Argan, Inc. (AGX) Market Cap & Valuation Ratios
Argan, Inc. (AGX) has a market cap of $4.6B, a trailing P/E of 26.2 and a price-to-sales ratio of 3.9, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-07-31 · read by EquiReason
AGXArgan, Inc.Follow AGX — free
—
Price chart with a free account
- Market cap
- 4.6B
- P/E TTM
- 26.2
- Dividend yield
- 0.6%
- 52-week
- —
- Next earnings
- 2 Dec, in 39 days
Peers
engineering & construction · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| AGX | 4.6 | 26.2 | 3.4 | 22.2 | 11.7% | +29% | 15% | 85% |
| FLR | 5.9 | — | 0.3 | — | -5.6% | -5% | -1% | -8% |
| KBR | 4.9 | 11.8 | 0.9 | 8.0 | 7.2% | -4% | 10% | 14% |
| ECG | 4.8 | 19.1 | 1.2 | 13.6 | 5.2% | +31% | 8% | 30% |
| ROAD | 4.7 | 32.6 | 1.8 | 13.5 | 3.7% | +42% | 9% | 9% |
| GVA | 4.7 | — | 1.1 | 10.6 | 10.1% | +22% | 6% | 16% |
| TPC | 4.0 | 33.1 | 0.6 | 11.2 | 15.4% | +25% | 4% | 21% |
| MYRG | 4.0 | 24.1 | 1.0 | 13.0 | 4.9% | +16% | 6% | 26% |
| LGN | 3.9 | — | 1.2 | 27.0 | 8.3% | +69% | 0.8% | 2% |
| EXPO | 3.7 | 34.7 | 5.7 | 26.2 | 2.9% | +13% | 20% | 44% |
| PRIM | 3.5 | 25.5 | 0.6 | 13.0 | 2.5% | +5% | 3% | 8% |
| Median of these 10 | 25.5 | 1.0 | 13.0 | 5.0% | +19% | 6% | 15% |
P/E 26.2 vs. a peer median of 25.5; EV/Sales 3.4 vs. 1.0. AGX's own P/E sits at the 55th percentile of its history.
Growth vs. price
each dot a company · hover or tap for valuesFLR and GVA and LGN have no P/E (earnings not positive) and are left out · hover or tap a dot for values.
Argan, Inc. — questions
- What is Argan, Inc.'s market cap?
- $4.6B.
- What is Argan, Inc.'s P/E ratio?
- 26.2 on trailing twelve-month earnings to 2026-07-31.
- What is Argan, Inc.'s price-to-sales ratio?
- 3.9.
Every figure on this page comes from Argan, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.